Tracking treatment delivery during brachytherapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data during High Dose Rate (HDR) brachytherapy treatments to verify the accurate delivery of the treatment plan. It utilizes medical imaging techniques such as CT, MRI, and ultrasound, combined with proprietary software, to monitor the brachytherapy source within the patient. The system will be set up beside the treatment table to automatically gather data without interfering with the clinical workflow. The collected data will be analyzed offline to ensure that treatment is not disrupted by any detected errors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Treatment site Gynaecology (Endometrium/Cervix) and prostate
* Treatment: HDR Brachytherapy
* Patient will be treated on CT Couch
* Mentally competent patient

Exclusion Criteria:

* Incapacitated patient

Where it's running

• Maastro
  Maastricht, Limburg, Netherlands Recruiting

Study contacts

• Principal investigator: Maaike Berbée — Radiotherapist
• Study coordinator: Janneke Waelen
• Email: janneke.waelen@maastro.nl
• Phone: +31 88 445 5334

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prostate-first versus combined prostate and pelvic lymph node radiation dose escalation in PSMA PET–staged node-positive prostate cancer

  This trial tests whether giving a stronger radiation boost to just the prostate first or to both the prostate and pelvic lymph nodes helps men whose prostate cancer has spread to nearby pelvic lymph nodes seen on PSMA PET.

  Recruiting Phase 2/3 Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość, Lublin Voivodeship · NCT07426094

• High Dose Rate Brachytherapy for Prostate Cancer Recurrence

  This study is testing if a special type of radiation treatment called High Dose Rate Brachytherapy can help men with prostate cancer that has come back after surgery feel better and have fewer side effects compared to regular radiation.

  Recruiting Clinica Universidad de Navarra, Universidad de Navarra · Pamplona, Foral Community of Navarre · NCT06982469

• Alpha DaRT treatment for skin squamous cell cancer in immunocompromised patients

  This study tests whether placing Alpha DaRT seeds directly into a skin squamous cell carcinoma can shrink tumors and improve outcomes in people with compromised immune systems.

  Recruiting at 6 sites Alpha Tau Medical LTD. · Gilbert, Arizona and 10 other locations · NCT06615635

• Reiki therapy to help patients with gynecological cancers undergoing brachytherapy

  This study tests if Reiki therapy can help reduce anxiety, pain, and depression in women with gynecological cancers who are about to start brachytherapy.

  Recruiting Phase 2 University of Utah · Salt Lake City, Utah · NCT05979610

• Combining radioactive seeds and fluzoparib for treating advanced soft tissue sarcoma

  This study is testing if combining radioactive seeds with a medication called fluzoparib can help people with advanced soft tissue sarcoma feel better and have better results than standard treatments.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT05894018

• Comparing two types of radiation therapy for prostate cancer treatment

  This study is testing whether a new type of radiation therapy for prostate cancer works better and is safer than a different method, while also looking at how well the treatment is tolerated by patients.

  Recruiting CHU de Quebec-Universite Laval · Québec · NCT05786742

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.